Repligen announced that it has appointed 20+ year industry veteran Olivier Loeillot to the newly created position of President and Chief Commercial Officer, CCO effective immediately. In his most recent role at Cytiva, he served as Bioprocess President from 2018 to 2022, overseeing the overall Bioprocess portfolio from cell culture media to purification resins and including process equipment, single-use technologies and enterprise solutions.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on RGEN:
- Repligen Appoints Olivier Loeillot as President and Chief Commercial Officer
- Repligen to acquire Metenova AB, terms not disclosed
- Repligen Announces Agreement to Acquire Fluid Management Innovator Metenova
- Repligen management to meet with Stephens
- Repligen appoints Garland as Chief Financial Officer